NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/05/2024
Voltar para busca
Dado oficial do USPTO
AILLIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
11/05/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
10, 44
Data de depósito
13/10/2020
Data de registro
13/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/09/2022
Última transação
13/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
Tokyo, JP
Examinador
SNYDER, NELSON B
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized term "Aillis" appearing in blue to the right of a blue hexagon design.
Titulares e representantes
Titulares
Aillis Inc.
Representantes
Bridget H Labutta Panitch Schwarze
Classificação técnica
Classes Nice
Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Medical imaging apparatusother than walking aids and crutchesan intraoral imaging aid being a shield that attaches to a camera to provide the camera with an unobstructed view of the mouth and throat and a protection from salivamucous membranebloodfor use in the diagnosis of infectious diseasesarteriosclerosisdiabeteshypertensionslingual cancerspharyngeal cancers; medical imaging apparatus for use in the diagnosis of influenza; medical imaging devices for use in the diagnosis of influenza
Classe 44
Medical analysis for the diagnosis and treatment of persons and for public health and provision of medical information in the field of clinical data on infectious diseasesother than for ophthalmic purposes; medical analysis for the diagnosis and treatment of persons and for public health and provision of medical information in the field of clinical data on influenza; medical information to medical institutions and doctors in the field of infectious diseasesother than for ophthalmic purposes; medical information to medical institutions and doctors in the field of influenza; medical advice in the field of infectious diseases using moving and still images of the inner surfaces of mouths and earsother than for ophthalmic purposes; medical advice in the field of infectious diseases to medical institutions and doctors using auscultatory soundsother than for ophthalmic purposes; medical advice in the field of infectious diseases to medical institutions and doctors using results of analysis of clinical data through artificial intelligence technologiesother than for ophthalmic purposes; medical advice to medical institutions and doctors in the field of the diagnosis of infectious diseasesother than for ophthalmic purposes; medical advice to medical institutions and doctors in the field of the diagnosis of influenza; rental of medical apparatus and instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/01/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/12/2022
FIMP
FINAL DISPOSITION PROCESSED
14/12/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
13/09/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/08/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
17/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
28/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/06/2022
PUBO
PUBLISHED FOR OPPOSITION
28/06/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/06/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/05/2022
EXPT
EXPARTE APPEAL TERMINATED
23/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2022
ALIE
ASSIGNED TO LIE
03/05/2022
ALIE
ASSIGNED TO LIE
28/04/2022
EXPI
EX PARTE APPEAL-INSTITUTED
26/04/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
26/04/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
26/04/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/04/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/10/2021
GNFR
FINAL REFUSAL E-MAILED
25/10/2021
CNFR
FINAL REFUSAL WRITTEN
25/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/09/2021
RFNT
REFUSAL PROCESSED BY IB
13/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/03/2021
RFRR
REFUSAL PROCESSED BY MPU
25/03/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/03/2021
CNRT
NON-FINAL ACTION WRITTEN
20/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
16/03/2021
DOCK
ASSIGNED TO EXAMINER
13/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/03/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AILLIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.